VLP-based RSV vaccine (VBI Vaccines)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVLP-based RSV vaccine (VBI Vaccines)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVbi Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVbi Vaccines Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A